CYCLOTRON

Tracer production and PET/CT go hand in hand. Because of the relatively short half-lives of PET radioisotopes, it’s a race against the clock to produce a radioactive isotope, synthesize it into a radiopharmaceutical and get it to the patient. To go in search of true discovery with PET, access to a cyclotron is necessary, and yet they are considered the most difficult and sophisticated part of a PET installation. Our Cyclotrons are also fully automated, so that isotope production requires no more than five simple steps from start to finish. As a result, routine operation can be performed by a trained hospital technician, which significantly simplifies the initial setup and daily operation of a facility.

Captura de Pantalla 2020-08-16 a la(s) 2
MOL.jpg

NUCLEAR MEDICINE 

800 SERIES

This new family of five nuclear medicine systems puts into practice everything we’ve learned over the course of 20 years by bringing the latest in SPECT/CT advancements to a wider range of clinical environments. Along with the breakthrough CZT-based NM/CT 870 CZT, the digital-ready NM/CT 870 DR and the SPECT-only NM 830, the 800 Series includes two eight-slice CT hybrids. With NM/CT 850, you'll find a low-dose CT for nuclear medicine hybrid imaging that delivers high specificity for localization and attenuation correction, while NM/CT 860 also provides diagnostic CT capabilities. We strategically paired these two systems with CT technology that makes state-of-the-art CT performance accessible to practices with emerging or more routine hybrid needs.

Captura de Pantalla 2020-08-16 a la(s) 2
MOL2.jpg

PET/CT

DISCOVERY IQ

Discovery™ IQ is the most widely utilized and trusted PET/CT system amongst clinicians across the globe. It was designed and engineered to be a scalable, high-performance diagnostic system with the capabilities to produce exceptional image quality while using less dose.

 

Most importantly, it was built on a platform intended to meet and exceed your clinical needs as they grow. To continue that momentum, we’re introducing Discovery IQ Gen 2. The next generation in PET/CT performance dedicated to improving your clinical outcomes, productivity and profitability.

MOL3.jpg
Captura de Pantalla 2020-08-16 a la(s) 2